A randomized, double-blind, placebo-controlled study of a novel pantothenic acid-based dietary supplement in subjects with mild to moderate facial acne
Yang M, Moclair B, Hatcher V, Kaminetsky J, Mekas M, Chapas A, Capodice J
Published in Dermatology and Therapy
Methodology
Twelve-week randomised, double-blind, placebo-controlled trial of a pantothenic acid-based supplement in 48 adults with mild to moderate facial acne.
Key Findings
Total lesion count and inflammatory lesion count decreased significantly versus placebo by week 12.
Conclusions
A high-dose pantothenic acid supplement reduced facial acne lesions over 12 weeks.
Limitations
Single small trial, proprietary multi-ingredient formulation, industry funded, no replication.
Supplements Studied
A pantothenic acid-based supplement significantly reduced total and inflammatory facial acne lesions versus placebo.
Outcomes Measured
Facial acne lesion counts fell significantly with a pantothenic acid-based supplement.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.